HIV

The Pharmacy Times® human immunodeficiency virus (HIV) resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

What can we help you find?

FDA's New Interactive, Mobile Database Provides HIV and ARV Information

Users will be able to export reports and collect metrics with the new interactive platform, as well as readily access the information on mobile platforms.

Mechanism That Drives HIV Resistance to Inhibitors Discovered

The mechanism behind HIV resistance affects the ability of integrase strand transfer inhibitors to bind and block the HIV enzyme integrase.

Top news of the day from across the health care landscape.

Experts Say Truvada Should Remain First Choice in Pre-exposure Prophylaxis for Most Patients with Risk of HIV

Robust data show the efficacy of tenofovir disoproxil fumarate with emtricitabine for pre-exposure prophylaxis in all priority populations with a risk for HIV.

Top news of the day from across the health care landscape.

Antiretroviral Therapy Does Not Restore Immunity in Vaccinated Patients with HIV

Antiretroviral therapy may not be entirely effective in restoring the immune protection resulting from viral infections or childhood vaccines received prior to becoming HIV-positive.

World Health Organization Develops Mobile App for PrEP Guidelines

The app takes the authoritative, evidence-based 2015 World Health Organization pre-exposure prophylaxis guidelines and adapts for a mobile device.

Top news of the day from across the health care landscape.

Study: HIV Infection Triggers Immune System Against Smallpox

The loss of immunity, also referred to as “HIV-associated immune amnesia,” could be related to why people with HIV who are on ART still have shorter lives on average than people without HIV, the study noted.

HIV Attacks Young Brain, Even with Early Treatment

Recent studies have shown that the HIV virus may affect the brains of children living with and exposed to the virus, even with early antiretroviral therapy (ART). HIV can disrupt neurodevelopment, which affects how children learn, reason, and function.

ZAP Gene Crucial First Step in Cells Identifying HIV

Study seeks to determine how HIV avoids the zinc-finger antiviral protein and how it binds the RNA.

Study Provides Insight Into HIV-Associated Cardiac Death Risk

Individuals with HIV have more QT interval variability than those without the disease, which may lead to the increased risk of sudden cardiac death.

Medication adherence plays a vital role in the success, or failure, of patients with HIV/AIDS. This Pharmacy Times® specialty page serves as a hub for all clinical news that pharmacists need to know about HIV treatment and possible prevention. The coverage includes breaking news coverage of approvals from the US Food and Drug Administration, key takeaways from the latest novel therapies in clinical trials, and notifications of updates to clinical guidelines for the conditions. Additionally, this page provides suggestions for ways that pharmacists can collaborate with physicians to help overall continued care.